Nanomaterial synthesis, an enabler of amyloidosis inhibition against human diseases
Abstract
Amyloid diseases are global epidemics with no cure currently available. In the past decade, the use of engineered nanomaterials as inhibitors or probes against the pathogenic aggregation of amyloid peptides and proteins has emerged as a new frontier in nanomedicine. In this Minireview, we summarize for the first time the pivotal role of chemical synthesis in enabling the development of this multidisciplinary field.
- This article is part of the themed collection: Recent Review Articles